-
Mashup Score: 3
Treatment with nadofaragene led to a complete response rate of 75% at 3 months.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease - 5 hour(s) ago
“We have to understand as providers that we’re not going to be the one and only conduit for this information anymore, which is a good thing, to be honest,” says Ian Metzler, MD, MTM.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1AUA 2025: What to watch for in urologic oncology - 7 hour(s) ago
We preview several noteworthy P2 presentations in the urologic oncology space.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 11
“You absolutely need to have a CT scan prior to the surgery to best identify and really intimately understand the kidney’s anatomy,” says Perry Xu, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 5
Overall, 71% of patients had no fragment greater than 2 mm following treatment.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
Merrill discusses the evolving non–muscle invasive bladder cancer treatment space.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
There is also a need to improve multidisciplinary care, according to Ekene Enemchukwu, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 4Urologist discusses drug cost savings, price transparency - 3 day(s) ago
“I think the great thing about Cost Plus Drugs is that, as we mentioned, it’s simple, but it’s also price transparent,” says Raymond Xu, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
“We are witnessing the dawn of teletreatment,” says Jihad Kaouk, MD, FACS.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Data presented at #JUA25 showed that nadofaragene firadenovec led to a 3-month complete response rate of 75% among Japanese patients with BCG-unresponsive NMIBC. #blcsm https://t.co/8EvIBHPdlV